Full-Time

Vice President

Immunology/Inflammation Biology

Posted on 3/4/2024

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops small molecule protein degraders

Biotechnology

Senior, Expert

Belmont, MA, USA

Required Skills
Communications
Requirements
  • PhD in Immunology or related discipline with a minimum of 15 years of relevant drug discovery experience
  • Experience in both large and small company environments is preferred
  • Demonstrated experience leading multiple small molecule drug discovery programs to IND with a track record of driving to success and making timely decisions in a dynamic and driven
  • Expertise in the subject area of Immunology, with a track record of translating molecular understanding of disease processes into competitive clinical positioning of projects
  • Highly proficient with cell biology and pharmacology with experience in integrating other disciplines, including DMPK and safety to identify and solve key issues in drug optimization
  • Excellent oral and written communication skills with the ability to manage discussions with a variety of audiences ranging from junior team members to Board of Directors
  • Demonstrated capability to collaborate with, lead, influence and inspire team members, stakeholders, peers and more junior staff
  • Enthusiastic, goal-driven, open-minded, creative and self-aware, with excellent communications, strategic and people-leadership skills
  • Willingness to \

Kymera Therapeutics, specializing in developing small molecule protein degraders for immunology-inflammation and oncology, utilizes their cutting-edge Pegasus platform to target and degrade disease-causing proteins effectively. This focus not only places them at the forefront of biomedical research within these critical health areas but also fosters a culture of technical excellence and leadership in medical innovation. An employment opportunity at this company promises a collegiate environment where scientific rigor is paired with a commitment to improving patient outcomes through pioneering therapies.

Company Stage

IPO

Total Funding

$879M

Headquarters

Watertown, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

10%

2 year growth

33%
INACTIVE